The National Committee for the Control of Viral Hepatitis will approve using Sovaldi and Harvoni to cure children with Hepatitis C within two weeks, Chairman Wahid Doss tells Al Mal. This follows the US FDA’s recent approval to use the medications to treat children. Doss expects the medication will be used starting from June.
More from Enterprise
Central Bank of Egypt looks to renew USD 2 bn Kuwaiti deposit as regional conflict stalls FDI conversions
The maturing USD 2 bn deposit is expected to be…
Miga guarantee unlocks USD 313 mn for National Bank of Egypt trade finance
Plus: Incolease taps securitization market with debut EGP 2 bn…
Ceasefire optimism triggers EGX30 rally and EGP recovery
The EGP gained around 2.5% on the greenback by the…
IBF & Company doubles down on logistics with Techno Metal acquisition
Plus: Lucky lands USD 23 mn in Series B round,…